TGThe Guardian·3hBusiness
score-0.55
GSK Invests £400m in UK Life Sciences, Moving 1,000+ Scientists to New Cambridge R&D Hub in £1.9bn Drive for Faster Drug Development
Original
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
“Lead emphasizes 'sweeping job cuts' negatively; investment framed as justification rather than primary benefit, creating cost-cutting tone.”